Watch PIII. Know when insiders buy.
One email the day a filing lands. Free.
PIII
P3 Health Partners Inc.
7.09
−0.51 −6.71%
USD · close Sep 23
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $1.5B +2.8%NET INCOME −$98.4MNET DEBT $98.6M52W 1.52 – 16.47SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $386.4M | +8.6% | — | $41.2M | $7.4M | — | -0.63 | −$61.9M | — | — | Aug 10 |
| Q1 2026 · Mar 31 | $386.4M | +3.5% | — | $8.2M | $1.2M | — | 0.32 | −$27.5M | — | — | May 14 |
| Q4 2025 · Dec 31derived | $384.8M | +3.8% | — | −$153.9M | −$75.5M | — | -23.08 | −$25.7M | — | — | Mar 26 |
| Q3 2025 · Sep 30 | $345.3M | −4.7% | — | −$44.2M | −$31.6M | — | -9.67 | −$15.4M | — | — | Nov 14 |
| Q2 2025 · Jun 30 | $355.8M | −6.2% | — | −$34.1M | −$20.4M | — | -6.23 | −$16.6M | — | — | Aug 10 |
| Q1 2025 · Mar 31 | $373.2M | −3.9% | — | −$38.1M | −$20.5M | — | -6.28 | −$33.5M | — | — | May 14 |
| Q4 2024 · Dec 31derived | $370.7M | +6.9% | — | −$138.5M | −$58.6M | — | -21.89 | −$57.2M | $0 | −$57.2M | Mar 26 |
| Q3 2024 · Sep 30 | $362.1M | +25.6% | — | −$107M | −$46.5M | — | -15.70 | −$22.6M | $0 | −$22.6M | Nov 14 |
| Q2 2024 · Jun 30 | $379.2M | — | — | −$31.3M | −$12M | — | -7.37 | −$10.2M | $0 | −$10.2M | Aug 14 |
| Q1 2024 · Mar 31 | $388.5M | — | — | −$43.8M | −$18.7M | — | -7.86 | −$20M | $0 | −$20M | May 15 |
| Q4 2023 · Dec 31derived | $346.9M | — | — | −$64.3M | −$25.5M | — | -0.22 | −$15.9M | −$212K | −$15.7M | Mar 28 |
| Q3 2023 · Sep 30 | $288.4M | — | — | −$33.8M | −$13.3M | — | -0.12 | −$7.6M | $387K | −$8M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.5B | — | −$270.3M | −$147.9M | -10.1% | -45.26 | −$91.2M | — | — | — | — |
| FY2024 · to Dec 31 | $1.5B | — | −$320.7M | −$135.8M | -9.1% | -54.06 | −$110.1M | $0 | −$110.1M | — | — |
| FY2023 · to Dec 31 | $1.3B | — | −$167.9M | −$57.8M | -4.6% | -0.63 | −$76M | $1.8M | −$77.9M | — | — |
| FY2022 · to Dec 31 | $1B | — | −$1.6B | −$270.1M | -25.7% | -6.50 | −$126M | $2.2M | −$128.3M | — | — |
| FY2020 · to Dec 31 | $491.1M | — | −$28.6M | −$31.4M | -6.4% | — | −$24.6M | $2.9M | −$27.5M | — | — |
| FY2019 · to Dec 31 | $145.5M | — | −$39.5M | −$42M | -28.8% | — | −$28.3M | $1.5M | −$29.7M | — | — |
Every number comes from P3 Health Partners Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.